{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/chest-infections-adult/","result":{"data":{"firstChapter":{"id":"90a18d8c-865e-5bc5-b97d-7cc8e2e8b178","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 8c5ea460-b976-4907-9a32-dfaaf08a4fe0 --><h1>Chest infections - adult: Summary</h1><!-- end field 8c5ea460-b976-4907-9a32-dfaaf08a4fe0 -->","htmlStringContent":"<!-- begin item 877aad8d-5a84-458b-a965-5fd11b887827 --><!-- begin field 453388b4-0dbf-43a2-8983-925f12315f6a --><ul><li>This CKS topic on chest infection covers the diagnosis and management of acute bronchitis and community-acquired pneumonia.</li><li>Acute bronchitis is defined as a lower respiratory tract infection which causes inflammation in the bronchial airways.<ul><li>Smoking cessation should be encouraged if relevant, and adequate analgesia and fluid intake advised. </li><li>Antibiotics are not routinely indicated, but should be offered immediately if the person is systemically very unwell, and should be considered (either immediately or as a back-up antibiotic prescription) if the person is at higher risk of complications.</li><li>Routine follow up is not necessary. However, if a person's symptoms rapidly or significantly worsen, they should be reassessed to exclude other diagnoses such as pneumonia. </li></ul></li><li>Pneumonia is an infection of the lung tissue in which the air sacs in the lungs become filled with microorganisms, fluid, and inflammatory cells, affecting the function of the lungs.</li><li>Chest X-ray is not usually necessary, but may be helpful to rule out pneumonia. </li><li>Treatment involves:<ul><li>Advising on self-care strategies.</li><li>Prescribing antibiotics. </li></ul></li><li>Adults with community-acquired pneumonia should be referred to hospital if:<ul><li>Symptoms and signs suggest a more serious illness or condition, or</li><li>Symptoms are not improving as expected with antibiotics.</li></ul></li><li>Referral of adults should also be considered if there is bacterial resistance to oral antibiotics or the person is unable to take oral medication.</li><li>Referral of young people with community-acquired pneumonia to hospital, or seeking specialist advice on further investigation and management should be considered. </li><li>The CRB-65 score may help with making a decision on referring adults. The score is determined by awarding one point for each of the following features: Confusion — recent; Respiratory rate of 30 breaths/min or greater; Blood pressure — systolic of 90 mmHg or less or diastolic of 60 mmHg or less; and 65 years old or older. <ul><li>CRB-65 score of 3 or more — urgent admission to hospital is required. </li><li>CRB-65 score of 1 or 2 — hospital assessment should be considered. </li><li>CRB-65 score of 0 — treatment at home should be considered, depending on clinical judgement and social circumstances.</li></ul></li></ul><!-- end field 453388b4-0dbf-43a2-8983-925f12315f6a --><!-- end item 877aad8d-5a84-458b-a965-5fd11b887827 -->","topic":{"id":"ae03d3aa-8b14-5b48-b837-2390b93d3b8c","topicId":"473ddaff-d0fe-4ba6-950d-21174782d383","topicName":"Chest infections - adult","slug":"chest-infections-adult","aliases":[],"chapters":[{"id":"90a18d8c-865e-5bc5-b97d-7cc8e2e8b178","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"e2a677e7-c782-5648-b8d3-af6f98f5ebf1","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"69d49ed5-19e9-5ca2-afb8-c08c815e9bd2","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"8d6a0737-dbc9-5f75-9d78-66599e03b11a","slug":"changes","fullItemName":"Changes"},{"id":"4e71b8d1-9ea4-57ff-8862-79109a739b30","slug":"update","fullItemName":"Update"}]},{"id":"c97ad137-7a88-5cd3-8a35-9f8609bc27e3","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"c3eaa151-d5d8-59ae-82d9-c89db380b247","slug":"goals","fullItemName":"Goals"},{"id":"73a8fdad-99ee-5ab8-a499-cd210cbe2ea7","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"f1989250-5170-573a-8d73-ccbd23325cc4","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"698f6236-86b5-5358-b8f6-3d986ce6e62c","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"7998bfca-0c1f-51aa-874d-18dd62dc65b5","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"2547690c-ac67-5a70-874e-e724acc82aad","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"b6392ff8-168f-5ece-b043-720dc73b7fdb","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"68203533-e202-5c04-b713-4d1f99e43d13","slug":"definition","fullItemName":"Definition"},{"id":"f05dcc7a-8622-5d0d-ba44-1a07f067c697","slug":"causes","fullItemName":"Causes"},{"id":"6dafb8b2-4871-5b47-ae51-7072fd0797ba","slug":"prevalence","fullItemName":"Prevalence"},{"id":"4f0c5b3d-3b3c-5c08-9f1d-f0fa9ed78995","slug":"complications-prognosis","fullItemName":"Complications and prognosis"}]},{"id":"dd5c4b0b-5449-5a20-b4b9-c1956ff731da","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"f8e2ad44-e229-588b-9421-5abb8d1366eb","slug":"assessment","fullItemName":"Assessment"},{"id":"8d401a7c-ada5-5bca-be9b-e0bde92f64d5","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"88bc2ad2-e15f-55af-a18a-db25d508dc89","slug":"management","fullItemName":"Management","subChapters":[{"id":"4ecbb38d-ec8f-5460-a468-aa870d049dfd","slug":"acute-bronchitis","fullItemName":"Scenario: Acute bronchitis"},{"id":"2afcbc23-a523-58d2-a490-ccfd81a2ce35","slug":"community-acquired-pneumonia","fullItemName":"Scenario: Community-acquired pneumonia"},{"id":"8782a14a-80d3-50d3-ab1b-9cc97e1fa22f","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"22189471-b7cd-534f-90d1-330da8d043b0","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"519bb329-75b0-5c14-84b8-9e6f162dcd2b","slug":"analgesia","fullItemName":"Analgesia"},{"id":"9e7786da-9ac8-50aa-bbac-6e15a0be127c","slug":"amoxicillin","fullItemName":"Amoxicillin"},{"id":"8cf724ea-6c07-5198-9916-b9d96d97acd2","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"4a74695a-622a-5bd3-b14f-cad47d602084","slug":"doxycycline","fullItemName":"Doxycycline"},{"id":"b500954c-b6b0-5e3b-ac55-0c2c6e2faf4c","slug":"erythromycin","fullItemName":"Erythromycin"}]},{"id":"8d0f9e0d-aea2-55e1-b4c1-b92b4c8161c4","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"96b9722b-40c5-5b7f-94ad-4223eb0a35e1","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"675135a4-558c-55ca-bcea-3c1d902517c3","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"e36b3e2e-a318-543d-bec5-980aa965fcc6","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"0cdeaef3-f31b-5054-8e9e-7589311e7281","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"a75aec21-edc0-55f4-810d-3cf44899b423","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"4085970a-642c-5d31-8c9f-414c768e84cb","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"76c4843c-7c5d-5f73-9c52-81b55b85ce03","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"ae03d3aa-8b14-5b48-b837-2390b93d3b8c","topicId":"473ddaff-d0fe-4ba6-950d-21174782d383","topicName":"Chest infections - adult","slug":"chest-infections-adult","aliases":[],"topicSummary":"Acute bronchitis and community-acquired pneumonia (CAP).","lastRevised":"Last revised in January 2021","nextPlannedReviewBy":"2024-09-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2024-08","nextPlannedReviewByDisplay":"August 2024","specialities":[{"id":"e174a859-759f-5b1d-898e-1a4155645e13","name":"Infections and infestations","slug":"infections-infestations"},{"id":"164e61aa-02a9-5edf-9943-5d891add3a7f","name":"Respiratory","slug":"respiratory"}],"chapters":[{"id":"90a18d8c-865e-5bc5-b97d-7cc8e2e8b178","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"e2a677e7-c782-5648-b8d3-af6f98f5ebf1","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"69d49ed5-19e9-5ca2-afb8-c08c815e9bd2","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"8d6a0737-dbc9-5f75-9d78-66599e03b11a","slug":"changes","fullItemName":"Changes"},{"id":"4e71b8d1-9ea4-57ff-8862-79109a739b30","slug":"update","fullItemName":"Update"}]},{"id":"c97ad137-7a88-5cd3-8a35-9f8609bc27e3","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"c3eaa151-d5d8-59ae-82d9-c89db380b247","slug":"goals","fullItemName":"Goals"},{"id":"73a8fdad-99ee-5ab8-a499-cd210cbe2ea7","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"f1989250-5170-573a-8d73-ccbd23325cc4","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"698f6236-86b5-5358-b8f6-3d986ce6e62c","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"7998bfca-0c1f-51aa-874d-18dd62dc65b5","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"2547690c-ac67-5a70-874e-e724acc82aad","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"b6392ff8-168f-5ece-b043-720dc73b7fdb","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"68203533-e202-5c04-b713-4d1f99e43d13","slug":"definition","fullItemName":"Definition"},{"id":"f05dcc7a-8622-5d0d-ba44-1a07f067c697","slug":"causes","fullItemName":"Causes"},{"id":"6dafb8b2-4871-5b47-ae51-7072fd0797ba","slug":"prevalence","fullItemName":"Prevalence"},{"id":"4f0c5b3d-3b3c-5c08-9f1d-f0fa9ed78995","slug":"complications-prognosis","fullItemName":"Complications and prognosis"}]},{"id":"dd5c4b0b-5449-5a20-b4b9-c1956ff731da","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"f8e2ad44-e229-588b-9421-5abb8d1366eb","slug":"assessment","fullItemName":"Assessment"},{"id":"8d401a7c-ada5-5bca-be9b-e0bde92f64d5","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"88bc2ad2-e15f-55af-a18a-db25d508dc89","slug":"management","fullItemName":"Management","subChapters":[{"id":"4ecbb38d-ec8f-5460-a468-aa870d049dfd","slug":"acute-bronchitis","fullItemName":"Scenario: Acute bronchitis"},{"id":"2afcbc23-a523-58d2-a490-ccfd81a2ce35","slug":"community-acquired-pneumonia","fullItemName":"Scenario: Community-acquired pneumonia"},{"id":"8782a14a-80d3-50d3-ab1b-9cc97e1fa22f","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"22189471-b7cd-534f-90d1-330da8d043b0","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"519bb329-75b0-5c14-84b8-9e6f162dcd2b","slug":"analgesia","fullItemName":"Analgesia"},{"id":"9e7786da-9ac8-50aa-bbac-6e15a0be127c","slug":"amoxicillin","fullItemName":"Amoxicillin"},{"id":"8cf724ea-6c07-5198-9916-b9d96d97acd2","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"4a74695a-622a-5bd3-b14f-cad47d602084","slug":"doxycycline","fullItemName":"Doxycycline"},{"id":"b500954c-b6b0-5e3b-ac55-0c2c6e2faf4c","slug":"erythromycin","fullItemName":"Erythromycin"}]},{"id":"8d0f9e0d-aea2-55e1-b4c1-b92b4c8161c4","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"96b9722b-40c5-5b7f-94ad-4223eb0a35e1","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"675135a4-558c-55ca-bcea-3c1d902517c3","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"e36b3e2e-a318-543d-bec5-980aa965fcc6","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"0cdeaef3-f31b-5054-8e9e-7589311e7281","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"a75aec21-edc0-55f4-810d-3cf44899b423","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"4085970a-642c-5d31-8c9f-414c768e84cb","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"76c4843c-7c5d-5f73-9c52-81b55b85ce03","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"ae03d3aa-8b14-5b48-b837-2390b93d3b8c"}},"staticQueryHashes":["3666801979"]}